OrthoPediatrics
OrthoPediatrics is a medical-device company specializing in orthopedic implants and surgical instruments for children.
Last updated August 31, 2026
AI crawler reads
1requests
1companies- Anthropic1
- Profile
- 1
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
OrthoPediatrics is a United States medical-device company focused on orthopedic treatment for children and adolescents. Founded in 2006 and based in Warsaw, Indiana, the company designs, develops, manufactures, and distributes implants and instruments intended for pediatric orthopedic procedures. Its product strategy is organized around clinical problems that are particularly relevant to growing bodies, including traumatic injuries and limb deformities, spinal deformities such as scoliosis, and pediatric sports-related conditions. The company was established to address what it describes as the specialized needs of pediatric orthopedic surgeons. Children are not simply smaller adult patients: their bones are still growing, anatomy changes over time, and implants may need to accommodate growth, preserve future treatment options, or support correction of complex deformities. OrthoPediatrics therefore concentrates on systems and instrumentation designed for use in children's hospitals and specialist orthopedic practices rather than competing as a general-purpose implant supplier across the entire adult market. According to the referenced company overview, OrthoPediatrics markets 24 surgical systems across areas including trauma and deformity, scoliosis, and sports medicine. Its portfolio includes pediatric fixation and support technologies, spinal systems, surgical connectors, screws, plates, nails, wires, and associated instruments. The company also holds patents covering technologies such as bottom-loaded pedicle screws, bone screws, graft fixation, pediatric long-bone fixation plates, pediatric intramedullary nails, compression bone-fragment wires, and convertible threaded compression devices. OrthoPediatrics has built distribution relationships to reach children's hospitals in the United States and customers in 34 countries. The reference material describes 31 independent distributors participating in this international distribution network. The company has also pursued technology and clinical relationships, including a 2016 license agreement with the Sydney Children's Hospitals Network and a 2017 partnership with Mighty Oak Medical involving FIREFLY Technology. Clinical research and education are central to the company's positioning. OrthoPediatrics holds exclusive rights to the Hamann-Todd Human Osteological Collection at the Cleveland Museum of Natural History, a human skeletal reference collection relevant to anatomical and orthopedic research. It has also licensed its name for the creation of a 501(c)(3) public charity dedicated to advancing pediatric orthopedics, extending the brand beyond commercial products into professional education and field development. The company became publicly traded in October 2017. The referenced account states that it offered 4,000,000 common shares at $13 per share and raised approximately $52 million. Its public-market identity is represented by the ticker KIDS. OrthoPediatrics remains positioned as a specialist orthopedic-device business whose differentiation rests on pediatric clinical focus, surgeon collaboration, specialized implants and instruments, and access to children's hospital networks.
History
OrthoPediatrics was founded in 2006 in Warsaw, Indiana, with a focused mission: to develop orthopedic implants and instruments for children. Its formation reflected the specialized nature of pediatric orthopedics. Pediatric patients have developing bones, changing anatomy, and treatment requirements that differ from those of adults, creating demand for dedicated systems rather than simple adaptations of adult hardware. The company developed its business around products for pediatric orthopedic surgery, including trauma and deformity correction, scoliosis treatment, and sports medicine. Its approach combined implant design, procedural instrumentation, surgeon collaboration, clinical research, and education. Over time, the portfolio expanded to 24 marketed surgical systems, giving the company a position across several major pediatric orthopedic treatment categories. OrthoPediatrics also developed relationships intended to extend its clinical and commercial reach. In 2016, it signed a license agreement with the Sydney Children's Hospitals Network. In 2017, it entered a partnership with Mighty Oak Medical involving FIREFLY Technology. Its distribution model included 31 independent distributors serving children's hospitals in the United States and customers in 34 countries globally. Research and professional education became additional elements of the company's identity. OrthoPediatrics holds exclusive rights to the Hamann-Todd Human Osteological Collection at the Cleveland Museum of Natural History. The collection provides an anatomical reference resource associated with orthopedic study. The company also licensed its name for the establishment of a 501(c)(3) public charity intended to support advances in pediatric orthopedics. The business became a public company in October 2017. The referenced company history reports an offering of 4,000,000 common shares at $13 per share, raising approximately $52 million. This marked a significant transition from a specialist privately held enterprise to a publicly financed medical-device company. The company's continuing identity is that of a pediatric orthopedic specialist rather than a broad adult orthopedic conglomerate, with its products and partnerships directed toward children's hospitals, pediatric surgeons, and conditions affecting growing patients.
- 2017
FIREFLY Technology partnership
[1]OrthoPediatrics entered a partnership agreement with Mighty Oak Medical involving FIREFLY Technology.
- 2017
Initial public offering
[1]OrthoPediatrics went public in October 2017, offering 4,000,000 common shares at $13 per share and raising approximately $52 million according to the referenced account.
- 2016
Sydney Children's Hospitals Network license agreement
[1]The company signed a license agreement with the Sydney Children's Hospitals Network.
- 2006
Company founded
[1]OrthoPediatrics was established in Warsaw, Indiana, to develop and commercialize orthopedic implants and instruments for pediatric patients.
Products and positioning
A specialist pediatric orthopedic-device company serving surgeons and children's hospitals with implants, instruments, clinical education, and procedure-focused systems designed for growing bones and pediatric orthopedic conditions.
Pediatric orthopedic fixation
Trauma and deformity systems
Systems intended for orthopedic trauma, limb deformity correction, and related fixation procedures in children. The category includes specialized implants and instruments designed around pediatric anatomy and the changing requirements of growing patients.
Pediatric spinal surgery
Scoliosis systems
Surgical systems for pediatric spinal deformity procedures, including treatment contexts associated with scoliosis. These offerings form one of the company's principal clinical areas and are supported by associated implants and instrumentation.
Pediatric sports medicine
Pediatric sports-medicine systems
Products and instruments intended for orthopedic sports-medicine procedures in children and adolescents. They extend the company's specialist portfolio beyond trauma, deformity, and spine care into activity-related orthopedic treatment.
Orthopedic implants
Pediatric fixation plates and intramedullary nails
Implant technologies for supporting or stabilizing pediatric long bones and other orthopedic structures. The referenced patent portfolio includes pediatric long-bone fixation plates and pediatric intramedullary nails.
Orthopedic fixation components
Bone screws, connectors, wires, and graft-fixation products
A group of fixation components and related technologies covering bone screws, surgical connectors, graft fixation, compression bone-fragment wires, and convertible threaded compression devices. These components support the company's broader procedure-based systems.
Surgical technology partnership · 2017
FIREFLY Technology
A technology associated with OrthoPediatrics through its 2017 partnership with Mighty Oak Medical. The available reference identifies the partnership but does not provide enough detail to characterize the complete product scope.
Brand decisions
2017
Public-market listingOtherBackground
OrthoPediatrics sought public financing as its specialist pediatric orthopedic business expanded its product portfolio and international distribution relationships.
Action taken
The company completed an initial public offering in October 2017, offering 4,000,000 common shares at $13 per share.
Aftermath
The offering reportedly raised approximately $52 million and established OrthoPediatrics as a publicly traded medical-device company.
IPO gross proceeds. Approximately $52 million (October 2017 initial public offering)
Recent events
Reported
OrthoPediatrics reports third-quarter 2021 results[2]
OrthoPediatrics announced its third-quarter 2021 financial results, reporting revenue of $25.1 million, a 13% increase year over year. The company maintained its full-year revenue guidance range of $97 million to $101 million.
Reported
OrthoPediatrics completes acquisition of ApiFix[3]
OrthoPediatrics acquired 100% of ApiFix. The acquisition was signed and closed on April 1, 2020; Trendlines held an 18.62% interest in ApiFix at closing.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/orthopediatrics · Editorial policy · How profiles are compiled